ACE2 and COVID-19: To date, there have been very few DNA methylation studies addressing the involvement of COVID-19 DNA methylation in regulating the angiotensin-converting enzyme 2 (ACE2) type I membrane receptor gene [72], which is present in arterial, lung type II alveolar cells, where it acts as a SARS-CoV-2 receptor.